---
schema_version: "secwatch.filing_event.v1"
accession: "0001664710-24-000086"
form_type: "8-K"
ticker: "KROS"
cik: "0001664710"
company_name: "Keros Therapeutics, Inc."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:37:52.096093+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Keros CEO to present at Guggenheim Healthcare Innovation Conference on Nov 13

## Summary
- CEO Jasbir Seehra will speak at the Guggenheim Healthcare Innovation Conference on November 13, 2024 at 3:30 p.m. ET.
- A live webcast will be available at wsw.com/webcast/guggen/kros/1967811; replay for 90 days on ir.kerostx.com.
- No financial results or material business updates were disclosed in the press release.

## SEC filing metadata
- accession: 0001664710-24-000086
- form_type: 8-K
- ticker: KROS
- cik: 0001664710
- company_name: Keros Therapeutics, Inc.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1664710/000166471024000086/0001664710-24-000086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1664710/000166471024000086/kros-20241106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001664710-24-000086
- JSON: https://secwatch.observer/filing/0001664710-24-000086.json
- Plain text: https://secwatch.observer/filing/0001664710-24-000086.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.